ERBB2 and breast cancer: Univariate analysis showed that DFS < 5 years, without adjuvant radiation therapy and PR-negative were risk factors of PFS in patients with advanced ER-high HER2-negative breast cancer (P = 0.027, P = 0.016, P<0.001, respectively.